KIT and neoplasm: Although no significant correlation was observed to tumor size, morphological subtype, risk classification, localization and KIT/PDGFRA mutation, it is interesting to note that seven of the nine TP53 mutated GIST were localized in the stomach including the one case with a TP53 mutation not altering the protein function.